Galveston, TX, United States of America

Robert L Seymour

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Profectus Biosciences, Inc., The University of Texas System. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert L. Seymour

Introduction

Robert L. Seymour is an accomplished inventor based in Galveston, TX (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work on recombinant viral vectors. His expertise and dedication to research have led to the development of valuable patents that advance scientific knowledge and applications.

Latest Patents

Robert L. Seymour holds a patent for "Recombinant Isfahan Viral Vectors." This patent encompasses certain embodiments directed to recombinant encoding a heterologous polynucleotide and methods of using the same. His work in this area demonstrates his commitment to exploring new frontiers in genetic engineering and virology.

Career Highlights

Throughout his career, Seymour has been associated with notable organizations, including the University of Texas System and Profectus Biosciences, Inc. His roles in these institutions have allowed him to collaborate with leading experts and contribute to groundbreaking research in his field.

Collaborations

Seymour has worked alongside talented individuals such as Demetrius Matassov and Rodion V. Gorchakov. These collaborations have enriched his research experience and fostered a dynamic exchange of ideas within the scientific community.

Conclusion

Robert L. Seymour's contributions to biotechnology through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to inspire advancements in the field, showcasing the importance of innovation in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…